Mitsui Chemicals’ newly formed $36.8m 321Force unit will focus on healthcare, mobility, ICT and sustainable materials.
The Japanese chemicals manufacturer Mitsui Chemicals has partnered venture capital firm Global Brain to launch a ¥5bn ($36.8m) investment vehicle.
The fund, named 321Force, will invest in seed-stage companies that dovetail with Mitsui Chemicals’ four areas of focus – life and healthcare, mobility, information and communications technology, and sustainable materials. It will also target new markets and technologies.
Global Brain, which already manages…
